ALEXANDRIA, Va., March 17 -- United States Patent no. 12,577,262, issued on March 17, was assigned to BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (Austin, Texas).

"Functionalized gold carbene napthaquinone complexes for use in the treatment of cancer" was invented by Jonathan L. Sessler (Austin, Texas), Sajal Sen (Austin, Texas), Jonathan F. Arambula (Austin, Texas) and Zhengrong Cui (Austin, Texas).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to functionalized gold carbene naphthoquinone compounds and salts thereof. In some aspects, these compounds can be used to treat cancer including cancers which are resistant to one or more other chemotherapeutic agents such as cispl...